JPMorgan Chase & Co. 13D and 13G filings for Intra-Cellular Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-10 12:36 pm Purchase | 2024-09-30 | 13G | Intra-Cellular Therapies, Inc. ITCI | JPMORGAN CHASE & CO JPM | 5,296,395 5.000% | 5,296,395 (New Position) | Filing |